This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Gerry Oster, PhD; Rebecca L. Tuden; Graham A. Colditz, MB, BS, DrPH

JAMA. 1987;257(2):203-208.

Abstract
A number of methods of prophylaxis can reduce the likelihood of postoperative deep-vein thrombosis in patients undergoing major orthopedic surgery. Using techniques of decision analysis, we examine the cost-effectiveness of several of these—warfarin sodium, low-dose subcutaneous heparin sodium, graduated compression stockings, intermittent pneumatic compression, heparin plus dihydroergotamine mesylate, and heparin plus stockings—compared with clinical diagnosis and treatment only. Our results show that 153 deaths per 10 000 patients occur when no prophylaxis is used; with most prophylaxes, this number is at least halved, and the most effective methods may reduce the number of deaths by three fourths. In addition, all of the prophylaxes considered are cost saving: average costs of care (including prophylaxis costs) are reduced by $19.40 to $181.60 per patient. Prophylaxis against deep-vein thrombosis in major orthopedic surgery therefore saves both lives and health care dollars.

(JAMA 1987;257:203-208)

Author Affiliations
From Policy Analysis Inc, Brookline, Mass (Dr Oster and Ms Tuden); Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, and Department of Epidemiology, Harvard School of Public Health, Boston (Dr Colditz).

Footnotes
Reprint requests to Policy Analysis Inc, 1577 Beacon St, Brookline, MA 02146 (Dr Oster).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A decision-tree model to estimate the impact on cost-effectiveness of a venous thromboembolism prophylaxis guideline
Ferrando et al.
Qual Saf Health Care 2009;18:309-313.
ABSTRACT | FULL TEXT  

Intervention targeted at nurses to improve venous thromboprophylaxis
Labarere et al.
Int J Qual Health Care 2007;19:301-308.
ABSTRACT | FULL TEXT  

A Pharmacist-Initiated Method to Improve Venous Thromboembolic Prophylaxis Rates in Medically Ill Patients
Stark and Vesta
Journal of Pharmacy Practice 2006;19:275-279.
ABSTRACT  

Incidence and Distribution of Lower Extremity Deep Vein Thrombosis in Rehabilitation Patients: Implications for Screening
Sachdev et al.
VASC ENDOVASCULAR SURG 2006;40:205-211.
ABSTRACT  

Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Geerts et al.
Chest 2004;126:338S-400S.
ABSTRACT | FULL TEXT  

The Economics of Venous Thromboembolism Prophylaxis: A Primer for Clinicians
Davidson et al.
Chest 2003;124 :393S-396S.
ABSTRACT | FULL TEXT  

Missed Opportunities for Prevention of Venous Thromboembolism : An Evaluation of the Use of Thromboprophylaxis Guidelines
Arnold et al.
Chest 2001;120:1964-1971.
ABSTRACT | FULL TEXT  

Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement
Bell and Goldhaber
Vasc Med 2001;6:23-29.
ABSTRACT  

Prevention of Venous Thromboembolism
Geerts et al.
Chest 2001;119 :132S-175S.
FULL TEXT  

An Epidemiologic Study of Risk Factors for Deep Vein Thrombosis in Medical Outpatients: The Sirius Study
Samama and for the Sirius Study Group
Arch Intern Med 2000;160:3415-3420.
ABSTRACT | FULL TEXT  

A Meta-Analysis of Thromboembolic Prophylaxis Following Elective Total Hip Arthroplasty
Freedman et al.
JBJS 2000;82:929-929.
ABSTRACT | FULL TEXT  

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
Samama et al.
NEJM 1999;341:793-800.
ABSTRACT | FULL TEXT  

Risks vs Benefits in Total Joint Surgery
Lotke and Heit
Chest 1999;116:843-845.
FULL TEXT  

Underuse of Venous Thromboembolism Prophylaxis for General Surgery Patients: Physician Practices in the Community Hospital Setting
Bratzler et al.
Arch Intern Med 1998;158:1909-1912.
ABSTRACT | FULL TEXT  

Is Impedance Plethysmography a Safe Test After Total Joint Replacement?
Dixon et al.
VASC ENDOVASCULAR SURG 1998;32:255-260.
ABSTRACT  

Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism: Current Recommendations
Hull and Pineo
CLIN APPL THROMB HEMOST 1998;4:96-104.
ABSTRACT  

Subcutaneous Low-Molecular-Weight Heparin vs Warfarin for Prophylaxis of Deep Vein Thrombosis After Hip or Knee Implantation: An Economic Perspective
Hull et al.
Arch Intern Med 1997;157:298-303.
ABSTRACT  

Cost-effectiveness of Enoxaparin vs Low-Dose Warfarin in the Prevention of Deep-Vein Thrombosis After Total Hip Replacement Surgery
Menzin et al.
Arch Intern Med 1995;155:757-764.
ABSTRACT  

A Meta-analysis of Methods to Prevent Venous Thromboembolism Following Total Hip Replacement
Imperiale and Speroff
JAMA 1994;271:1780-1785.
ABSTRACT  

Prevention of Venous Thromboembolism: An Update
Clagett
PERSPECT VASC SURG ENDOVASC THER 1994;7:71-84.
 

The Female Role in the Transmission of HIV Infection
Hansel et al.
Arch Fam Med 1993;2:870-873.
ABSTRACT  

Diagnosis, Treatment, and Prevention of Pulmonary Embolism: Report of the WHO/International Society and Federation of Cardiology Task Force
Goldhaber et al.
JAMA 1992;268:1727-1733.
ABSTRACT  

The Prevalence of Risk Factors for Venous Thromboembolism Among Hospital Patients
Anderson et al.
Arch Intern Med 1992;152:1660-1664.
ABSTRACT  

Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature: Are the Methods Being Used Correctly?
Udvarhelyi et al.
ANN INTERN MED 1992;116:238-244.
ABSTRACT  

Fall Mortality and Related Medical Conditions in the Elderly: The Association with Pulmonary Embolism
Mendlein et al.
J Aging Health 1990;2:326-340.
ABSTRACT  

External Pneumatic Calf Compression in Patients with Malignancy
Dwek and Buff
ANN INTERN MED 1988;109:344-345.
ABSTRACT  

Prevalence and Prevention of Deep Venous Thrombosis of the Lower Extremities in High-Risk Pulmonary Patients
Ibarra-Perez et al.
ANGIOLOGY 1988;39:505-513.
ABSTRACT  

Prophylaxis Against Deep-Vein Thrombosis
Lotke and Day
JAMA 1988;259:687-688.
ABSTRACT  

Dextran in the Prophylaxis of Deep-Vein Thrombosis
Bergqvist
JAMA 1987;258:324-325.
ABSTRACT  

Prophylaxis for Deep-Vein Thrombosis
Bernstein
JAMA 1987;257:2291-2291.
ABSTRACT